IRIS
SCALISE, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.089
AS - Asia 4.238
EU - Europa 3.925
SA - Sud America 974
AF - Africa 195
Continente sconosciuto - Info sul continente non disponibili 157
OC - Oceania 6
Totale 17.584
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.926
SG - Singapore 1.465
VN - Vietnam 842
UA - Ucraina 795
BR - Brasile 719
RU - Federazione Russa 683
CN - Cina 602
TR - Turchia 432
IE - Irlanda 412
DE - Germania 387
HK - Hong Kong 347
SE - Svezia 340
IT - Italia 308
DK - Danimarca 292
FR - Francia 265
FI - Finlandia 208
KR - Corea 161
GB - Regno Unito 103
AR - Argentina 99
CI - Costa d'Avorio 80
BD - Bangladesh 75
MX - Messico 71
IN - India 65
CA - Canada 61
EC - Ecuador 43
IQ - Iraq 40
CO - Colombia 39
ID - Indonesia 34
ZA - Sudafrica 34
JP - Giappone 28
IR - Iran 27
PL - Polonia 24
PY - Paraguay 24
MA - Marocco 21
NL - Olanda 20
VE - Venezuela 18
UZ - Uzbekistan 16
ES - Italia 14
EG - Egitto 13
PH - Filippine 13
PK - Pakistan 13
TN - Tunisia 12
BE - Belgio 11
CL - Cile 11
AT - Austria 10
KE - Kenya 10
JO - Giordania 9
PE - Perù 9
CR - Costa Rica 8
BG - Bulgaria 7
MY - Malesia 7
OM - Oman 7
RO - Romania 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
KZ - Kazakistan 6
LT - Lituania 6
DO - Repubblica Dominicana 5
NP - Nepal 5
PS - Palestinian Territory 5
SA - Arabia Saudita 5
AU - Australia 4
AZ - Azerbaigian 4
BO - Bolivia 4
CY - Cipro 4
DZ - Algeria 4
MD - Moldavia 4
AL - Albania 3
BH - Bahrain 3
CG - Congo 3
ET - Etiopia 3
EU - Europa 3
GT - Guatemala 3
HU - Ungheria 3
IL - Israele 3
PA - Panama 3
PT - Portogallo 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GE - Georgia 2
HR - Croazia 2
KW - Kuwait 2
LY - Libia 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
CM - Camerun 1
Totale 17.410
Salva come PNG Salva come JPEG
Città #
Ashburn 1.346
Singapore 888
Jacksonville 783
Chandler 497
Fairfield 486
Dallas 419
Dublin 412
Boardman 368
Hong Kong 333
San Jose 327
Wilmington 285
Ho Chi Minh City 272
Council Bluffs 229
Woodbridge 228
Hanoi 216
New York 210
Houston 201
Seattle 190
Moscow 170
Cambridge 166
Princeton 158
Lawrence 156
Beijing 155
San Mateo 155
Lauterbourg 128
Ann Arbor 127
The Dalles 123
Hefei 103
Los Angeles 100
Des Moines 83
Abidjan 80
Turin 63
São Paulo 59
Milan 57
Buffalo 52
San Diego 51
Da Nang 46
Munich 43
Santa Clara 30
Orem 29
Helsinki 28
Haiphong 27
Mexico City 27
Miano 26
Chicago 25
London 25
Turku 25
Shanghai 24
Izmir 23
Rio de Janeiro 22
Tokyo 22
Warsaw 20
Belo Horizonte 18
Denver 18
Johannesburg 17
Montreal 17
Biên Hòa 15
Chennai 15
Phoenix 15
Tashkent 15
Wuhan 15
Brasília 14
Dhaka 14
Guangzhou 14
Norwalk 14
Amsterdam 13
Atlanta 13
Hải Dương 13
Nuremberg 13
Stockholm 13
Baghdad 12
Falls Church 12
Manchester 12
Ottawa 12
Can Tho 11
Curitiba 11
Mumbai 11
Asunción 10
Brussels 10
Columbus 10
Guayaquil 10
Jakarta 10
Kilburn 10
Nairobi 10
Ninh Bình 10
Salt Lake City 10
Brooklyn 9
Buenos Aires 9
Bắc Giang 9
Caracas 9
Medellín 9
Elk Grove Village 8
Frankfurt am Main 8
Guarulhos 8
New Delhi 8
Nha Trang 8
Poplar 8
Porto Alegre 8
Thái Bình 8
Ankara 7
Totale 10.671
Salva come PNG Salva come JPEG
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 334
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 268
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 232
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 209
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 202
Anticryptosporidial activity of paromomycin. 202
ACTIVITY OF THE NEW ANTIFUNGAL TRIAZOLE, POSACONAZOLE, AGAINST CRYPTOCOCCUS NEOFORMANS 191
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 186
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 179
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 166
Epidemiology and microbiology of surgical wound infections. 159
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 155
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 153
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 152
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 151
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 151
[Prevalence of Toxocara spp in public playgrounds in a town of Central Italy] 148
[Giardiasis: a parasitic disease of continued topicality. Study of prevalence among a selected adult population] 148
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 145
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 143
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 143
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 142
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 142
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 140
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 133
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 133
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 133
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 133
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 132
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections. 131
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 131
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 131
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 129
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 127
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 127
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 127
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 125
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 125
Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. 124
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 124
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 124
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 123
Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. 123
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 123
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 123
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. 122
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 121
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. 120
Interactions of posaconazole and flucytosine against Cryptococcus neoformans. 119
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 119
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 118
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. 117
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 117
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 116
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. 116
In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia. 116
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 116
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 115
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. 115
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 115
LL-37 protects rats against lethal gram-negative sepsis. 113
In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates. 113
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 113
Effect of mono-dose intraperitoneal cecropins in experimental septic shock 112
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. 111
In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum. 109
In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides. 109
Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infections 109
In vitro activities of tachyplesin III against Pseudomonas aeruginosa. 108
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 108
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. 108
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide 107
In-vitro activity of topoisomerase inhibitors against Pneumocystis carinii. 106
In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics. 105
In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans. 105
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 105
In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteria. 104
Treatment of Staphylococcus aureus Biofilm infection by the quorum sensing inhibitor RIP 103
Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosis. 103
In- vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii. 103
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 102
In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH(2) and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant gram-positive cocci. 102
In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species 102
Efficacy of Tachyplesin III, Colistin and Imipenem against Multiresistant Pseudomonas aeruginosa 101
Prevalence of intestinal parasites among individuals with allergic skin diseases. 101
In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum. 101
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 101
In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients. 100
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection. 100
In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans. 100
Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy. 100
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 100
Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline. 100
Unusual clinical presentation of infection due to Flavimonas oryzihabitans. 100
In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens 99
Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy 99
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 99
Carbapenem-induced resistance to beta-lactams in Pseudomonas aeruginosa. 99
Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis. 98
Interactions between triazoles and amphotericin B against Cryptococcus neoformans. 97
Totale 12.839
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.771
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.053 0 239 0 50 9 105 40 63 73 192 36 246
2022/20231.652 199 166 132 117 122 179 2 80 482 8 125 40
2023/20241.001 209 18 43 189 198 194 14 7 0 4 20 105
2024/20252.336 278 197 175 112 105 148 261 92 467 98 190 213
2025/20266.600 298 564 559 831 588 401 1.143 702 655 498 78 283
2026/2027449 261 188 0 0 0 0 0 0 0 0 0 0
Totale 17.584